Indication of metronomic chemotherapy for metastatic breast cancer: Clinical outcomes and responsive subtypes

The survival of patients with metastatic breast cancer (MBC) has not improved, despite recent advances in therapeutic strategies. This is mainly due to the fact that cytotoxic agents cannot be administered over a long period, even if they exhibit favorable activity, due to treatment-related side eff...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Clin Oncol
Asıl Yazarlar: KONTANI, KEIICHI, HASHIMOTO, SHIN-ICHIRO, MURAZAWA, CHISA, NORIMURA, SHOKO, TANAKA, HIROAKI, OHTANI, MASAHIRO, FUJIWARA-HONJO, NAOMI, DATE, MANABU, TERAMOTO, KOJI, HOUCHI, HITOSHI, YOKOMISE, HIROYASU
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2016
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4887815/
https://ncbi.nlm.nih.gov/pubmed/27284428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.841
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller